
DOGWOOD THERAPEUTICS INC
DWTXNASDAQπ #3938 by market capEarnings Nov 4US Equity
$1.84β² $0.00 (+0.27%)
Live1hβ
24hβ² 0.3%
7dβΌ 0.8%
14dβ² 18.4%
30dβ² 31.1%
1yβΌ 62.5%
π¦Market Cap
$62M
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
β
Otter Score
50
Weak
Trading Snapshot
- Day Range
- $1.81 β $1.85
- 52-Week Range
- $1.28 β $9.50
- Volume
- $5.51B
- Avg Volume
- $5.37B
- Shares Outstanding
- 33.6M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- $1M
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-10.60
- Dividend Yield
- β
Why Investors Own DWTX
- βHigh-growth profile β revenue up +41.9% YoY with expanding US Equity exposure.
- βHealthy economics β 74% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
β οΈ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$6Mβ² +40.3% YoY
Gross Margin (TTM)
73.9%β² +3.9% YoY
Operating Income (TTM)
$2Mβ² +40.3% YoY
Free Cash Flow (TTM)
$2Mβ² +40.3% YoY
About DOGWOOD THERAPEUTICS INC
A company profile for DOGWOOD THERAPEUTICS INC isnβt available yet β check back soon.
π¦¦
Otter Score Breakdown
βπQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
Overall Score
Weak
50/100
Analyst Ratings
βConsensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026